ArticleCureus2025
COVID-19-Related Challenges Among Patients With Hearing Loss Prescribed Hearing Aids, and Their Awareness of Telehealthcare.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Remote cochlear implant programming: a systematic review of clinical effectiveness and implementation outcomes.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2026Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background The COVID-19 pandemic presented serious challenges in accessing health care, especially for individuals with hearing loss who rely heavily on both sight and sound. Communication and routine care, such as hearing aid management, were negatively impacted by the mandatory use of face masks and the limited availability of clinics. Objective This study aimed to assess the difficulties faced by patients with hearing loss who were prescribed hearing aids during the COVID-19 pandemic and to evaluate their awareness and acceptance of telehealthcare services. Methods A cross-sectional study was conducted at the Armed Forces Hospital, Southern Region in Aseer Province, Saudi Arabia. The sample included 210 individuals aged 18-65 years who had a medical diagnosis of hearing loss and were using conventional hearing aids prescribed between 2017 and 2019. SPSS version 22 was used for both descriptive and inferential statistical analyses. Results Among the 210 respondents, 109 (51.9%) reported difficulty communicating with individuals wearing face masks, primarily due to an inability to lip-read (n = 15, 7.3%) and muffled speech (n = 75, 35.8%). Despite this, 130 participants (61.9%) experienced no difficulty using their hearing aids while wearing a mask. Although 166 (80.2%) preferred in-person consultations over telehealth, 69 (32.8%) reported being less likely to visit a clinic due to the pandemic. Communication challenges were more prevalent among users with bilateral (n = 42, 20.0%) and severe hearing loss (n = 57, 27.1%). Statistically significant associations were found between hearing loss type and both preference for in-person visits (χ² = 6.01, p = 0.049) and mask-related communication difficulty (χ² = 12.37, p = .002). Conclusion The use of face masks and restricted clinic access during the COVID-19 pandemic significantly inconvenienced individuals using hearing aids. Although tele-audiology presents a promising alternative, uptake remains low due to limited patient awareness and acceptance. Investment in telehealth infrastructure and expanded patient education is essential to ensure continuity of hearing care during future public health emergencies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.